Table 3.
miRNA | Disease | Country | Ethnicity | Source | No. of cases/controls | Investigation method | Changes of miR expression | Target gene | References |
---|---|---|---|---|---|---|---|---|---|
miR-146a | RA | Egypt | Arab | Whole blood | 25/25 | qPCR | ↑ | — | [104] |
RA | Japan | Asian | PBMC | 6/5 | qPCR∗ | ↑ | — | [62] | |
RA | China | Asian | PBMC | 69/69 | qPCR | ↑ | — | [105] | |
RA | Egypt | Arab | PBMC | 52/56 | qPCR | ↑ | — | [55] | |
RA | Egypt | Arab | PBMC | 70/60 | qPCR | ↑ | — | [106] | |
RA | Canada | — | PBMC | 11/10 | qPCR | ↑ | — | [107] | |
RA | USA | — | PBMC | 16/9 | qPCR | ↑ | TRAF6, IRAK1 | [26] | |
RA | Switzerland | European | Serum | 34/16 | qPCR | ↓ | — | [60] | |
RA | Poland | European | Serum | 13/16 | qPCR | ↓ | — | [29] | |
RA | USA | European | Plasma | 168/91 | qPCR | ↑ | — | [108] | |
RA | China | Asian | Plasma | 25/20 | qPCR∗ | ↓ | — | [109] | |
RA | Japan | Asian | Plasma, synovial fluid | 30/30 | qPCR | ↑ | — | [61] | |
RA | China | Asian | Synovial tissue | 17/3 | qPCR∗ | ↑ | — | [102] | |
RA | China | Asian | FLS | 12/10 | qPCR | ↓ | TLR4 | [57] | |
RA | Japan | Asian | CD4+ T | 33/12 | qPCR | ↑ | FAF1 | [54] | |
RA | Germany | European | Treg | 61/49 | qPCR | ↓ | STAT1 | [110] | |
AS | China | Asian | Serum | 70/68 | qPCR† | ↑ | — | [66] | |
AS | Spain | European | Plasma | 53/57 | qPCR‡ | ↑ | — | [74] | |
AS | Switzerland | European | Plasma | 24/29 | qPCR∗ | ↓ | — | [69] | |
AS | China | Asian | Hip capsule | 30/30 | qPCR | ↑ | DKK-1 | [67] | |
miR-155 | RA | Canada | Native American | Whole blood | 18/12 | qPCR | ↑ | — | [111] |
RA | Japan | Asian | PBMC | 6/5 | qPCR∗ | ↑ | — | [62] | |
RA | China | Asian | PBMC | 45/25 | qPCR | ↑ | SOCS1, TNFa, IL-1B | [112] | |
RA | Canada | — | PBMC | 11/10 | qPCR | ↑ | — | [107] | |
RA | USA | — | PBMC | 16/9 | qPCR | ↑ | — | [26] | |
RA | China | Asian | PBMC, FLS | 26/23 | qPCR∗ | ↑ | IKBKE | [113] | |
RA | Egypt | Arab | Serum | 100/100 | qPCR | ↑ | — | [114] | |
RA | Japan | Asian | Plasma, synovial fluid | 30/30 | qPCR | ↑ | — | [61] | |
RA | China | Asian | Plasma | 25/20 | qPCR∗ | ↓ | — | [109] | |
RA | USA | European | Plasma | 168/91 | qPCR | ↑ | — | [108] | |
RA | China | Asian | FLS | 89/49 | qPCR | ↑ | FOXO3a | [115] | |
RA | UK | European | CD14+ T | 9/8 | qPCR∗ | ↑ | — | [116] | |
RA | Germany | European | Treg | 61/49 | qPCR | ↓ | — | [110] | |
RA | UK | European | Monocyte | 24/22 | qPCR | ↑ | CCR2, CCR7 | [117] | |
AS | China | Asian | Serum | 70/68 | qPCR | ↑ | — | [66] | |
miR-21 | RA | China | Asian | Plasma | 25/20 | qPCR∗ | ↑ | — | [109] |
RA | Italy | European | Plasma | 28/20 | qPCR | ↓ | — | [94] | |
RA | China | Asian | CD4+ T, PBMC | 25/20 | qPCR | ↓ | STAT3, STAT5 | [93] | |
AS | China | Asian | Whole blood | 122/122 | qPCR | ↑ | PDCD4 | [91] | |
miR-22 | RA | China | Asian | RASF | 40/40 | qPCR | ↓ | SIRT1 | [118] |
RA | UK | European | Serum | 12/12 | Microarray | ↑ | — | [119] | |
RA | China | Asian | FLS | 48/30 (OA) | qPCR | ↓ | Cyr61 | [120] | |
AS | Spain | European | Plasma | 53/57 | qPCR‡ | ↑ | — | [74] | |
miR-30a | RA | China | Asian | Synovial tissue | 7/12 (OA) | qPCR | ↓ | Beclin-1 | [121] |
AS | USA | — | Plasma | 15/5 | Microarray | ↓ | — | [98] | |
miR-125a | RA | China | Asian | Plasma | 25/20 | qPCR∗ | ↓ | — | [109] |
RA | Japan | Asian | Plasma | 102/104 | qPCR∗ | ↑ | — | [122] | |
RA | USA | European | Plasma | 168/91 | qPCR | ↑ | — | [108] | |
AS | Spain | European | Plasma | 53/57 | qPCR‡ | ↑ | — | [74] | |
miR-221 | RA | Egypt | Arab | PBMC | 30/20 | qPCR | ↑ | — | [123] |
RA | China | Asian | Serum, FLS | 22/18 | qPCR | ↑ | — | [124] | |
AS | Switzerland | European | Plasma | 24/29 | qPCR∗ | ↓ | — | [69] | |
miR-29a | RA | China | Asian | Serum, synovial tissue, FLS | 20/10 | qPCR | ↓ | STAT3 | [87] |
AS | Switzerland | European | Plasma | 24/29 | qPCR∗ | ↓ | — | [69] |
↑/↓: up/downregulation; RA: rheumatoid arthritis; AS: ankylosing spondylitis; PBMC: peripheral blood mononuclear cell; FLS: fibroblast-like synoviocytes; RASF: RA synovial fibroblasts; ∗microarray screening; †sequencing screening; ‡NanoString screening.